Gene · 10062
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sesamin regulates breast cancer through reprogramming of lipid metabolism. | J Biomol Struct Dyn | 2026 | 40233124 | PubTator, text mining | PubMed |
| Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials. | Int J Transl Med (Basel) | 2025 | 41586160 | PubTator, text mining | PubMed |
| PRMT3 at the crossroads of inflammation: dual roles in metabolic reprogramming and immune dysregulation in chronic diseases. | Front Immunol | 2025 | 41583428 | PubTator, text mining | PubMed |
A therapeutic approach of LC-MS characterised MFER-Mc against alcohol and NDEA induced hepatocellular carcinoma activity through LXR-α, LXR-β and HMG-CoA pathway: an in-silico, in-vitro and in-vivo study. | Med Oncol | 2025 | 41455855 | PubTator, text mining | PubMed |
| Traditional Chinese medicine monomers: a new strategy against diabetic kidney disease by regulating cholesterol efflux. | Front Nutr | 2025 | 41377559 | PubTator, text mining | PubMed |
| Foam cells: tracing the diverse cellular origins and their linked signaling pathways. | J Transl Med | 2025 | 41351176 | PubTator, text mining | PubMed |
| Dexmedetomidine and dezocine targets (NR1H3 and ADRB1) are potential prognostic biomarkers for breast cancer. | Discov Oncol | 2025 | 41315135 | PubTator, text mining | PubMed |
| Correction: MiR-7683-3p from M2-exosomes attenuated atherosclerosis by activating the PPARγ-LXRα-ABCG1 pathway mediated cholesterol efflux of vascular smooth muscle cell derived foam cells. | J Nanobiotechnology | 2025 | 41276840 | PubTator, text mining | PubMed |
| Multivariate genome-wide analyses of insulin resistance unravel novel loci and therapeutic targets for cardiometabolic health. | Nat Commun | 2025 | 41249132 | PubTator, text mining | PubMed |
| Bisphenol S disrupts human sertoli cell function through NR1H3 degradation: Mechanistic insights from integrated bulk and single-cell transcriptomics. | Ecotoxicol Environ Saf | 2025 | 41241997 | PubTator, text mining | PubMed |
| Bioactive Glycosylated Flavonoids Exhibiting LXR Agonist Activity from a Lauraceae Colombian Species. | Plants (Basel) | 2025 | 41225791 | PubTator, text mining | PubMed |
| Inferring residue level hydrogen deuterium exchange with ReX. | Commun Chem | 2025 | 41214241 | PubTator, text mining | PubMed |
| Novel Strategies against Hepatocellular Carcinoma through Lipid Metabolism. | Oncol Res | 2025 | 41179299 | PubTator, text mining | PubMed |
| Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence. | J Biochem Mol Toxicol | 2025 | 41140031 | PubTator, text mining | PubMed |
| Development and validation of a novel sodium-overload related genes signature for prognostic prediction in breast cancer: integrating bioinformatics and experimental approaches. | Front Immunol | 2025 | 41103406 | PubTator, text mining | PubMed |
| METAP2 inhibits K48-linked ubiquitination of YTHDF2 to promote ovarian cancer progression. | Oncogene | 2025 | 41102384 | PubTator, text mining | PubMed |
| HPV as a Molecular Hacker: Computational Exploration of HPV-Driven Changes in Host Regulatory Networks. | Viruses | 2025 | 41012596 | PubTator, text mining | PubMed |
| Sinapic Acid Regulates the LXRα-ABCG5/8 Axis in the Hepatocytes: A Potential Strategy for Cholesterol Gallstone Management. | Pharmaceuticals (Basel) | 2025 | 41011256 | PubTator, text mining | PubMed |
| Enhancing the Efficiency of Active Chemical Identification in Environmental and Biological Mixtures. | Environ Health (Wash) | 2025 | 40995478 | PubTator, text mining | PubMed |
| Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy. | Front Pharmacol | 2025 | 40994643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10062/papers?page=5